Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 609
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01683149 | Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies | ||
| NCT00977548 | Erlotinib Study for Myelodysplastic Syndrome (MDS) | ||
| NCT02336984 | A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS | ||
| NCT06144606 | Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL) | ||
| NCT06597565 | A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC | ||
| NCT00868114 | Direct Tumor Injection KLH-Pulsed Dendritic Cells in Unresectable Pancreatic Cancer | ||
| NCT00031564 | Phase II Study of a B7-1 Gene-Modified Autologous Tumor Cell Vaccine and Systemic IL-2 | ||
| NCT04974619 | Adaptation Of An HPV Education Resource To Promote HPV Vaccination | ||
| NCT01804179 | Colorectal Cancer Awareness, Research, Education and Screening (CARES) | ||
| NCT06236425 | TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC | ||
| NCT02960620 | Therasphere for Unresectable Primary or Secondary Liver Neoplasia | ||
| NCT06660368 | BCL2i CLAG-M in R/R Acute Myeloid Leukemia | ||
| NCT01859026 | A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR Mutation | ||
| NCT04879940 | Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization | ||
| NCT06660355 | Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy | ||
| NCT00955916 | CLAG Gleevec in Relapsed or Refractory Acute Myeloid Leukemia (AML) | ||
| NCT02901548 | Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder | ||
| NCT05651828 | Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma | ||
| NCT05170334 | Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma | ||
| NCT06483139 | Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy | ||
| NCT02780609 | Selinexor Plus High-Dose Melphalan (HDM) Before Autologous Hematopoietic Cell Transplantation for Multiple Myeloma | ||
| NCT01419210 | Pilot Program to Personalize Care & Improve Quality of Life for Women With Ovarian Cancer | ||
| NCT00606008 | A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma | ||
| NCT01434550 | Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer | ||
| NCT05677360 | HPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS) | ||
| NCT04242173 | Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC | ||
| NCT05649969 | STRONG Program for Cancer Patients | ||
| NCT06947083 | Elranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed Myeloma | ||
| NCT00127036 | Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A) | ||
| NCT00325416 | Study of Melphalan and Topotecan (MT) Followed by Autologous Stem Cell Rescue in Patients With Multiple Myeloma. | ||
| NCT03077126 | Feasibility Study of Ultrasound Elastography Detecting Prostate Cancer | ||
| NCT07250087 | Asciminib Maintenance Therapy Following alloHCT or CAR T to Prevent Relapse in Adults With Ph+ALL | ||
| NCT03406715 | Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC) | ||
| NCT07774104 | A Structured Peer Support Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation | ||
| NCT04150874 | Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE | ||
| NCT02032810 | Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma | ||
| NCT06553885 | Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC | ||
| NCT03575325 | Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia | ||
| NCT05041335 | Wet Heparinized Suction for Abdominal Cancer | ||
| NCT07447635 | Testing an MBI for Smoking Cessation and Alcohol Use Among Cancer Survivors | ||
| NCT00246103 | Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies | ||
| NCT01450046 | Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects | ||
| NCT03511196 | Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer | ||
| NCT00617591 | Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed Multiple Myeloma (MM) | ||
| NCT02978443 | A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab | ||
| NCT07090174 | CASCADE: Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV | ||
| NCT05524935 | Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma | ||
| NCT00495625 | Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC) | ||
| NCT00153933 | Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma | ||
| NCT05579847 | Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy |
